Apr. 27 at 3:08 PM
$NTIP never thought NTIP would become an algo playground. Bad target imo, trading under cash value, pending reval of Iliad Bio stake in Q1 10-Q, HFT patent trials set for 2027, now succesful Cox Google patents appeal could have value. CEO owns 30%. Active buyback available. What folks new to NTIP don't realize is the Cox/Google case was largely considered dead before last week.
NTIP has shown annual losses last few years but majority is an accounting writedown of Iliad Bio stake as they burned cash on valuable pertussis vaccine studies. Iliad actually produced meaningful IP with that cash. Iliad just raised 115 million in an oversubscribed funding round. I expect NTIPs stake will be marked back up to at least the
$7M they invested and could be
$10-20M. that will hit in upcoming earnings release.
Good luck getting out of this algo-boys as liquidity returns to prior levels and revised book value comes in.
